National Health Investors (NHI) Tops Q3 FFO by 1c/Share; Boosts FY12 FFO Outlook
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $70.19 --0%
Financial Fact:
Total operating expenses: 29.78M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total operating expenses: 29.78M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
National Health Investors (NYSE: NHI) reported Q3 normalized FFO of $0.80, $0.01 better than the analyst estimate of $0.79. Revenue for the quarter came in at $25.51 million versus the consensus estimate of $22.51 million.
National Health Investors sees FY2012 EPS of $3.15-3.18, versus the consensus of $3.12.
For earnings history and earnings-related data on National Health Investors (NHI) click here.
National Health Investors sees FY2012 EPS of $3.15-3.18, versus the consensus of $3.12.
For earnings history and earnings-related data on National Health Investors (NHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
- Sunbelt Rentals (SUNB) PT Raised to $71 at BofA Securities
- Signet Jewelers (SIG) Tops Q2 EPS by 47c, Misses on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
